Polyphor Ltd. announced that its shareholders elected four new Members of the company's board of directors, including two senior Pharma professionals, Jerry Karabelas and Jean-Jacques Garaud, capital markets specialist Bernard Bollag, and Polyphor CEO Jean-Pierre Obrecht. Jerry Karabelas was the CEO of Worldwide Pharmaceuticals, head of all healthcare businesses and a member of the Executive Committee at Novartis AG. Jean-Jacques Garaud served until 2012 as Head of Roche Pharma Research & Early Development and a Member of the Enlarged Roche corporate executive committee.

These four new board members are replacing Sir Jack Baldwin, Peter Grogg, Jürg Meier, and René Muttenzer, who all retired after reaching the age of 70. The new Board elected Jerry Karabelas as its Chairman and Kuno Sommer as Vice-chairman.